Valrocemide is primarily investigated for its potential therapeutic applications in the treatment of epilepsy and other neurological disorders. It has shown promise as an anticonvulsant agent, particularly in managing seizures that are resistant to standard treatments. Research suggests that it may modulate neurotransmitter activity and stabilize neuronal membranes, contributing to its efficacy in reducing seizure frequency and severity. Additionally, valrocemide is being studied for its neuroprotective properties, which could be beneficial in conditions involving neuronal damage or degeneration. Its relatively favorable safety profile compared to some traditional antiepileptic drugs makes it a candidate for further clinical development. Ongoing studies aim to explore its broader applications in neurological and psychiatric conditions, potentially offering new treatment options for patients with limited responses to existing therapies.